the GardenING sales exhibition will take place in Ingelheim for the second time the park on the Jungau will be transformed into a colourful sea of flowers and plants for two days Regional and national exhibitors will present a colourful range of plants and garden design there is something for garden lovers of all ages GardenING also presents high-quality garden furniture practical garden tools and fine arts and crafts If you want to turn your own garden or balcony into a blooming oasis Visitors can get inspiration for creative garden design find out about current trends or sustainable gardening on the extensive exhibition grounds Garden professionals will provide tips on all aspects of flowering phases Whether lush variety or understated elegance - at GardenING you can find everything you need to turn your home garden into a picturesque dream or retreat The range extends from practical climbing aids handmade wickerwork and stylish fire pots to natural cosmetics oils and natural products from the farm shop The multi-generation centre's repair café offers a practical repair service for broken garden tools TV gardening expert Heike Boomgaarden will once again act as curator this year and will provide expert guidance for the event The GardenING offer is rounded off by a varied supporting programme consisting of specialist lectures nature tours and hands-on activities for children With the kind support of Rheinhessische Energie- und Wasserversorgungs-GmbH and Sparkasse Rhein-Nahe Location: Park on the Jungau in IngelheimOrganiser: Ingelheimer Kultur- und Marketing GmbHTelephone: 06132.710 009 0E-mail: info@ikum-ingelheim.deWebsite: www.ikum-ingelheim.de Drug Discovery and Development Ingelheim am Rhein, Germanywww.boehringer-ingelheim.com 2022 Revenues ($USD) : $19,487,900,000.002022 Revenues (foreign currencies) : €18,500,000,0002022 R&D spend : $5,267,000,000.002022 Number of Employees : 53,155Fiscal Year End : 12/31/22Leader : Chair Hubertus von Baumbach Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media Privacy Policy | Advertising | About Us APÉRO at the wine cellarSwap a desk for a wine table The event series ‘Apero - swap desk for wine table’ is entering a new round In the cosy ambience of the Winzerkeller's front garden it's time to end the day with a glass of wine and small culinary delights ‘APÉRO’ always takes place on Tuesdays from 6 pm to 9 pm Weekly changing live bands provide the right musical accompaniment from 6.30 pm to 8.30 pm Catering is provided by the Winzerkeller Restaurant and the Ingelheim Vinothek The event is supported by Sparkasse Rhein-Nahe Location: Grounds in front of the Ingelheim WinzerkellerStart: 18:00 hrsEnd: 21:00Organiser: Ingelheimer Kultur und Marketing GmbHTelephone: 06132.710 009 0E-mail: info@ikum-ingelheim.deWebsite: www.ikum-ingelheim.de The growth of the vines in the wine-growing region of Rhine-Hesse is shaped by its proximity to Germany's longest river Famous sites such as the Rote Hang are only a few steps away from the waves of the Rhine - the perfect microclimate for top wines The holiday region of Rhine-Hesse also thrives on its proximity to historic cities such as Worms Alzey and Mainz - you can experience the perfect symbiosis of regional culinary delights and urban lifestyle at one of the varied wine events for example: APÉRO am Winzerkeller (03.06.2025) in Ingelheim am Rhein You too can combine a delicious wine experience with cultural enjoyment at one of the wine festivals in Rhine-Hesse. You can also find more varied events throughout Rhineland-Palatinate in the Rhineland-Palatinate calendar of events You can find even more information about the wine festivals in Rhine-Hesse and your trip to our region on our website: Holidays in Rhine-Hesse The time has finally come: the Smurfs are conquering the musical stage the cheerful blue creatures that were created in Belgium in 1958 and conquered the world from there The brand new musical ‘The Smurfs’ will be performed live on stages large and small from spring 2025 Look forward to an exciting adventure with Papa Smurf Smurfette and the little blue friends with their endearing quirks and abilities - and of course their adversary Gargamel whose only goal is to destroy the cheerful Smurfs and their village of Smurfville Brand new songs and an original stage show will capture the hearts of musical fans awaken fond childhood memories across the generations and cast a spell over young and old alike Look forward to the Smurfiest family musical of all time Further information can be found here located on the banks of the Rhine in Ingelheim invites you to linger by the Rhine and listen to music from the Leinpfad stage or the main stage with various live bands The festival is organised by Ingelheimer Kultur und Marketing GmbH (IkUM) and takes place over three days from 25 to 27 July Guests can expect an attractive programme with live music an artists' market and children's entertainment There will also be the traditional classic car show The Ingelheim wineries will set up their tents under the willows on the banks of the Rhine Atmospheric lighting and awnings create an inviting ambience The chill-out area on the festival grounds hosted by the Yellow youth and cultural centre Look forward to an unforgettable weekend - whether young or old Travelling by public transportThis is how it works with the Ingelheim e-ticketUse the free public transport service in Ingelheim and Saturday andSunday you don't pay a cent for a single ticket with the FAIRTIQ app.cent You can reach the site from the railway station on the 611 lineThe nearest bus stop to the event site is called ‘FreiWeinheim Travelling by carComing from the A 60 motorway please take the motorway exitIngelheim West motorway exit and follow the signs to the ferry To programme the ferry in your navigation system 55218 IngelheimCar parking spaces are available at the venue You can also use the public car parks (for a fee) in the city centre: Neuen Mitte From here you can also use the free bus service Barrier-free car parksYou will find designated parking areas directly at the entrance area that the majority of the stands are set up on grassy ground Wheelchair users may find this difficult to navigate Location: Jungaue on the banks of the Rhine in IngelheimOrganiser: Ingelheimer Kultur- und Marketing GmbHTelephone: 06132.710 009 0E-mail: info@ikum-ingelheim.deWebsite: www.ikum-ingelheim.de Die von Ihnen gewünschte Seite kann leider nicht (mehr) aufgerufen werden When the Groß-Gerau Safari Park closed its doors in 1984 Peter Schweikhard was raising two tiger babies with a bottle The non-profit association was founded in 2006 The first came in 2007 Tiger offspring into the world There are now seven Bengal tigers living in the Waldeck Tiger Garden the animals can be admired free of charge from 4 meters away from Friday to Sunday Guided tours are also offered: - Groups: by appointment only - € 4.00 per person - Public tours: Sundays at 3 p.m at least 7 total participants) - personal tiger tour: ONLY by appointment each additional one costs 4 € Opening hours: Friday: 3 p.m Please book the tours directly with "Tiger-Garten Waldeck e.V." Even before the stylish glass door has quietly closed behind you, your attention is drawn towards the shelves behind the inviting counters of the wine bar Gleaming wine glasses are lined up beside fine wines just like the friendly wine expert who welcomes you and your companion to your wine tasting the culinary highlight of your break in the multifaceted city of Ingelheim Wine tasting in the Ingelheim wine cellar with one of the most beautiful vinotheques in Germany Wine enjoyment in the "Rheinhessen AUSGEZEICHNET-Vinothek" in the Ingelheimer Winzerkeller The Ingelheimer Winzerkeller forms the city’s heart in terms of both wine and culture It is an unforgettable experience combining the traditional and the modern Within the historic walls of the building that was once home to the Ingelheim winemakers association you will find not only a wine bar combining the offerings of nearly 30 winemakers and one distillery but also a cultural meeting point hosting regular top-class events The unique atmosphere strikes you as soon as you walk in with a blend of old walls and modern architecture that really makes the heritage of wine production something almost tangible There is a good reason why Ingelheim has developed a name as a centre for red wine you are surprised to find a new favourite tipple at the wine tasting Every mouthful reveals the richness of knowledge and passion the local winemakers put into their production As you savour all the flavours around your tongue you think back on the exciting day behind you: The Ingelheim wine cellar combines a mixture of old walls and modern architecture It was still pleasantly cool when you and your companion set out in the morning for the Historic Tour of Ober-Ingelheim The many little corners of the red wine town are as multifaceted in character as the wines produced here the ‘Engelthal’ Cistercian nunnery and the unique Ingelheim mountain church it is part of the best preserved fortified church in the south and west of Germany you were able to admire the Romanesque church tower with its late Gothic battlement and to observe many elements of pre-Reformation chancel fittings and the artistic stained glass of the Middle Rhine from around 1400.All these styles from different eras have been harmoniously blended like the flavours in the fine wine another tasting glass of which is currently being poured for you and the multimedia options to find out more about it from the KAISERPFALZ app to the virtual 360° tour sound like the perfect addition to what you have experienced so far a blend of historic heritage and lively modernity reminding you that you still have dinner to enjoy in the Winzerkeller restaurant You have not yet decided which of the regional specialities you are going to try there will be a perfect wine to go with it The imperial palace served as a residence and seat of government for emperors and kings until the 11th century The city history museum of the imperial palace provides information about the exciting Roman period and the early Middle Ages Manage signals from detection through risk evaluation and mitigation Deliver right content to the right station Ensure role-based qualification and compliance Simplify postmarket surveillance for medical devices Optimize QC labs for real-time batch release Advance scientific exchange across channels Automate medical inquiry intake & fulfillment Get insights into KOLs and their ecosystems Integrated commercial data for faster insights Digitize study binders and enable monitoring Securely organize and access sponsor systems and sustainable products to market faster Accelerate innovation and drive operational excellence at enterprise scale "If you look at the role of customer-facing teams today and their expectations and we have many other tools and technologies that make them more powerful." Global Head of Customer Facing Execution Excellence Where customers and Veeva product leaders share information and ideas Cloud-based Software for the Global Life Sciences Industry The deal includes an upfront payment and up to 100 million euros in milestones Amal's lead candidate is a vaccine for colorectal cancer expected to enter the clinic later this month A large family-owned drugmaker in Germany plans to shell out more than $350 million to buy a cancer vaccine maker in Switzerland Ingelheim am Rhein, Germany-based Boehringer Ingelheim said Monday it would spend up to 325 million euros – or $364.5 million – to acquire Geneva-based Amal Therapeutics The deal includes an upfront payment and up to 100 million euros in milestone payments Amal’s lead product candidate is ATP128 a therapeutic cancer vaccine that has been in preclinical development and is expected to start first-in-human clinical trials in Stage IV colorectal cancer later this month The company describes its immunization platform as being able to turn a “cold tumor” into a “hot tumor,” meaning one that can be infiltrated with immune cells “Acquiring Amal is part of Boehringer Ingelheim’s long-term strategy to enhance our existing position as an innovator of novel cancer therapies which leverage cutting-edge scientific discoveries and their applications,” Boehringer Ingelheim board member Michel Pairet said in a statement “We want to pioneer new paradigms of biology-based care for cancer patients and the technologies and expertise developed at Amal are critical to our efforts.” only one cancer vaccine has Food and Drug Administration approval in the U.S. namely Dendreon’s Provenge (sipuleucel-T) in advanced prostate cancer The first oncolytic virus to receive FDA approval was Amgen’s Imlygic (talimogene laherparepvec) Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry This webinar will explore how a banking platform approach could be the resource for your company Discover what tools are essential for efficient safe surgical extractions in today’s health care landscape Multinational pharmaceutical company Boehringer Ingelheim has appointed Patricia Alonso as fleet manager in Canada Before starting her position in April (2022) Alonso most recently held fleet management positions for machinery manufacturing company Johnston Equipment from Canada and US-based chemical manufacturing Praxair Inc Boehringer Ingelheim is set on developing breakthrough therapies and innovative healthcare solutions in areas of unmet medical needs for both humans and animals Want to capture the attention of the International Fleet and Mobility leaders Contact us and become our partner! WIKIFLEET is a free collaborative encyclopaedia providing knowledge about car fleet management all over the world The Global Fleet MARKETPLACE is the ONE guide to find fleet & mobility providers worldwide Marketplace directories and magazines in our knowledge center Knowledge Center Contact us This website is using a security service to protect itself from online attacks The action you just performed triggered the security solution There are several actions that could trigger this block including submitting a certain word or phrase You can email the site owner to let them know you were blocked Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page Despite recent advances, cancer remains one of the biggest healthcare challenges we face today. It is a leading cause of death globally and, in 2020, accounted for an estimated 9.9 million deaths1 has a long-term commitment to deliver scientific breakthroughs and develop innovative cancer treatments to positively transform the lives of patients Our commitment to innovation has resulted in pioneering treatments for lung cancer and we are now advancing a unique clinical development pipeline of new therapeutic agents both cancer-cell directed agents and immune-oncology therapies to help combat many different types of cancer Overall, approximately 5–7% of tumours display MDM2 amplifications3 such amplifications are more common in some tumour types than others with an incidence of up to 90% in some types of advanced soft tissue sarcoma (STS) Despite advances in the treatment for other cancers over the past decade the standard-of-care treatment for patients with advanced STS is still chemotherapy; hence patient outcomes are poor and there is a clear need for new therapeutic options with improved efficacy and better tolerability Blocking the MDM2–p53 interaction to reactivate wild-type p53 function is therefore a promising cancer therapeutic strategy we have developed a compound designed to target the MDM2–p53 interaction: the oral small-molecule MDM2–p53 antagonist BI 907828 This novel agent has a dual mechanism of action: direct targeting of tumour cells and exertion of immune-cell modulatory effects (Fig BI 907828 binds directly to MDM2 and blocks its interaction with p53 cell-cycle arrest and apoptosis in tumour cells with wild-type TP53 status Activation of p53 also promotes an anti-tumour immune response by increased CD8+ T-cell infiltration in the tumour and induces anti-tumour immune memory BI 907828 and immune checkpoint inhibitors targeting PD-1 may show synergistic activity in combination The MDM2–p53 antagonist BI 907828 has a dual mechanism of action (MOA) combining both direct cell-targeted and immune-modulatory activities Based on encouraging preclinical activity4 BI 907828 is currently under clinical investigation in two ongoing phase I clinical trials in patients with advanced solid tumours: a phase I trial of BI 907828 as monotherapy a phase I trial of BI 907828 in combination with the anti-PD-1 antibody ezabenlimab (BI 754091) comparing BI 907828 with doxorubicin in first-line treatment of patients with advanced dedifferentiated liposarcoma will start recruiting in early 2022 (NCT05218499) The data from both ongoing and upcoming clinical studies with BI 907828 as monotherapy and in combination will provide more evidence about the relevance of such an innovative targeted therapy in various tumour types susceptible to MDM2–p53 blockade many advances in cancer treatment have provided benefit to patients; however there remain multiple areas of unmet medical need Although further clinical investigation is needed progress so far with the MDM2–p53 antagonist BI 907828 is just one example of the efforts being made in the fight against cancer we believe that our long-term focus on both cancer cell- and immune cell-directed therapies together with our close collaboration with the oncology community will continue to provide novel therapies and improved outcomes for cancer patients 2Boehringer Ingelheim RCV GmbH & Co KG The authors would like to thank Jane Saunders of Ashfield MedComms for providing editorial assistance in the development of this paper Download references the regular bus service will be operated with battery-electric buses It has been taken the decision to buy eight electric bus units without subsidies The chosen model is the Iveco E-Way / Heuliez GX337 Elec according to the webmedia Boostyourcity.de Delivery of the vehicles is scheduled for October 2021 These vehicles will be used by Transdev subsidiary INGmobil The investment for the purchase of eight vehicles will be about 4.72 million euros “This decision is groundbreaking for the development towards sustainable mobility The e-buses will be ambassadors for Ingelheim’s goal of a CO2-neutral city,” said Christiane Döll Member of the City Council and responsible Department of the Environment The news is reported on the webmedia Boostyourcity.de with local news on Rheinland-Pfalz and Hessen regions electrive.net highlighted in early November that as the electric are being purchased without subsidies there were political disputes in the run-up to the purchase An application for funding by INGmobil was apparently unsuccessful The SPD had abstained from voting in the committees as it was considered uneconomical to operate the electric buses without subsidies © Copyright 2012 - 2025 | Vado e Torno Edizioni | All rights reserved | P.I a multinational pioneer in drug contract manufacturing in China will invest EUR174 million (USD193 million) in the Asian country till 2023 BI will upgrade its veterinary healthcare facilities and boost production state-backed news outlet The Paper reported yesterday the Ingelheim am Rhein-headquartered firm's China chief executive.  IB already has China's largest animal health lab in terms of investment the Asian Veterinary Research & Development Center The center was originally opened in 2012.  China is one of BI's most important markets and Shanghai is the center of talent with an increasingly progressive business environment The company will participate in the China International Import Expo for the first time this year bringing its latest achievements in the fields of both human and veterinary healthcare It has invested EUR300 million in China with more than half of that going to Shanghai BI was the first biopharma firm to participate in China's Pharmaceutical Marketing Authorisation Holder pilot program to develop and sell its drugs in the country CH Boehringer Sohn AG & Co KG is the parent company of the Boehringer Ingelheim pharmaceutical group which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein they are a global group of companies producing pharmaceuticals for the worldwide market With reported revenue of $17.9 billion in 2017 they are one of the largest pharmaceutical companies in the world the company’s research focuses around the areas of respiratory diseases oncology and diseases of the central nervous system One of its early commercial successes was the reproduction of lactic acid created by the human body future Nobel Prize winner Professor Heinrich Otto Wieland set up the company’s research department Karl Thomae GmbH re-opened in Biberach an der Riss with a staff of 70 – the foundation for its future expansion it acquired Pfizer’s veterinary programme and a subsidiary had been established in Greece: Boehringer Ingelheim Hellas the company has 146 subsidiaries around the globe and its corporate headquarters are in Frankfurt It employs more than 50,000 people with a long list of successful products in prescription medicine Join our newsletter to receive regular updates on our stories Orbis Terra Media GmbH will use the information you provide on this form to be in touch with you and to provide Newsletter updates Please let us know all the ways you would like to hear from us: You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us or by contacting us at info@tharawat-magazine.com We will treat your information with respect For more information about our privacy practices please visit our website you agree that we may process your information in accordance with these terms Jean-Michel Boers doesn”™t often speak to the media but in an exclusive interview with the Business Journal he spoke of Boehringer Ingelheim”™s future as it marks 50 years in the U.S While understandably proud of Boehringer Ingelheim USA”™s reaching its golden anniversary this year the president and CEO notes that parent company Boehringer Ingelheim was actually founded by Albert Boehringer in Ingelheim am Rhein “So obviously we were doing business with the U.S The 294-acre campus is the pharma giant”™s North American headquarters but Boers noted that it has a number of other sites across the U.S. in an unusual arrangement where Boehringer Ingelheim paid €4.7 billion in cash to Sanofi to acquire its animal health division Sanofi acquired Boehringer”™s consumer health care business Thomae The world”™s largest private pharma company Boehringer worldwide reported a 3% rise in net sales in 2020 to about $23.2 billion and a 22% increase in operating income to $5.6 billion The North American division posted a 1% increase in net sales last year Although there have doubtless been attempts at wooing the company away from Ridgefield Boers insisted the company is there to stay “We”™ve become very attached to this site,” he said “The fact that we”™re in the Northeast between Boston and New York makes Connecticut a good place to be when it comes to attracting talent.” including R&D and back-office operations in addition to its executives All together there are close to 9,000 employees throughout the country and over 50,000 worldwide The company”™s products include the type 2 diabetes medication Jardiance whose worldwide revenue was up 22% last year to nearly $1.15 billion; and Ofev a treatment for idiopathic pulmonary fibrosis whose sales increased last year by 38% to $2.34 billion Global sales of other familiar names like asthma and COPD treatment Spiriva fell by 13% to $2.17 billion while Trajenta/Jentadueto declined by 3% to $1.83 billion Covid-19 came as a bolt from the blue for Boehringer; unlike most it had to keep most of its R&D team in its on-site laboratories Boers said the firm implemented full safety precautions R&D isn”™t just a major part of the company”™s business ”” BI spent nearly $4.5 billion on R&D in 2020 7% more than in the previous year ”” but due to the long development and FDA review processes any disruption could further negatively impact the delivery of medicine And it is studying treatments for conditions affected by Covid Although it announced in March that it was discontinuing the Phase 2 trial of a compound for reducing the risk or severity of acute respiratory distress syndrome (ARDS) in patients hospitalized for the virus and requiring non-invasive oxygen support Boers said another antibody treatment via inhalant is continuing to be tested Ultimately the company expects to have most everyone back on the Ridgefield campus over the next several weeks While the work-from-home procedures went smoothly although we will see what the future looks like Offering flexibility for our employees and future employees will play a part and as a result we will probably be a more agile organization.” Boers also expressed admiration for the pharmaceutical sector at large “The speed at which the industry was able to offer highly efficacious vaccinations is quite extraordinary,” he said “It shows how important it is to invest in health care in the U.S.” “We still need to look at the long-term effects of Covid.” Another challenge for BI and the rest of the industry is ”” well Keeping medicines affordable is an ongoing issue while spending millions on rebates and offering discounts to promote prescription drugs Merck and Bristol-Myers Squibb have all recently reported downturns in average net prices with Merck saying that 45.5% of its gross U.S One part of BI”™s business unlikely to be affected is its philanthropy Boers chairs the Boehringer Ingelheim Cares Foundation board of directors which is dedicated to improving the health and lives of people and animals recently committed up to $450,000 in employee-directed funds to strengthen communities and address unmet needs Boers explained that the company”™s active U.S employees are being encouraged to direct a one-time $50 donation (for the 50th anniversary) from BI Cares to one of the more than 40 eligible nonprofit causes in its matching gifts program employees will each have an opportunity to direct an additional $5,000 BI Cares donation “There is a lot of volunteering in our company,” he noted “which is probably because of our mission to providing first-in-class products and services to the health care industry and to our patients.” BI Cares invested over $1 million in nonprofit programs in the communities where its employees live and work The company also donated about $71 million in medicines to its various nonprofit partners along with a number of food banks and animal shelters Mention “animals” in the same breath with “pharmaceuticals” and many people envision grisly images of testing on dogs While Boers acknowledged that BI does engage in such testing he said that it “unfortunately is necessary” since new medications cannot be tested on humans before they have been done on animals “It helps us understand the toxicity of products,” he said “But of course we work under the most recent highest standards with the authorities We recognize we have a responsibility and the highest respect for animals.” BI confirmed that it would no longer use or fund the so-called “despair test,” which involved placing mice rats and other small animals into inescapable beakers filled with water The putative reason for such tests was to study depression in animals and how certain medications could treat that condition Boers said he agreed with a recent statement by Hubertus von Baumbach the corporation”™s chairman of the board of managing directors predicting a slight year-over-year increase in net sales “We are pretty confident that we can make sure the U.S has the access to quality medicines that our innovative approach makes possible,” he said that Boehringer Ingelheim”™s motto is “Value Through Innovation.” This page is available to subscribers. Click here to sign in or get access. and website in this browser for the next time I comment Δdocument.getElementById( "ak_js_1" ).setAttribute( "value" CNN (CNN) — Former Vice President Mike Pence said Sunday while receiving the John F CNN (CNN) — Former Vice President Mike Pence said Sunday while receiving the John.. Trending Westchester Conference on forensic entomology: a report by Jens Amendt “Insects & Wine”was the motto of an international conference held in Ingelheim am Rhein – which is known for its red wine – from June 12 to 14 Fifty-five participants from 14 countries including South Africa Brazil and Canada met to discuss the latest findings and developments in forensic entomology The event was organized by University Hospital Frankfurt’s Institute of Forensic Medicine the institute has been the site of intensive research into the biology and ecology of carrion insects The knowledge gained can be applied nationwide in the routine work of investigating capital offenses – for instance in determining the time or the circumstances of a death The conference was held under the aegis of the European Association for Forensic Entomology It was divided into several themed sessions and had some unusual features including a focus on the establishment and uses of human forensic taphonomy facilities often known colloquially as “body farms.” These are outdoor laboratories where research is carried out to understand the decomposition processes in human cadavers under natural conditions (in which carrion insects play a major role) The body farms also enable the simulation of case scenarios for the investigation authorities and are used to train forensic technicians and human remains detection (HRD) dogs but to date none has been set up anywhere in Europe The biologists at Frankfurt’s Institute of Forensic Medicine some legal and bureaucratic obstacles remain the Frankfurt scientists invited some high-profile help to the conference has already opened three “body farms” in Australia and Canada and her lecture entitled “Human decomposition facilities – What can we learn from these bodies of Knowledge?” was impressively persuasive It is clear that the network of these facilities has to be expanded worldwide to provide information relevant to all climate zones and inhabited areas and to satisfy the different investigation authorities’ numerous requirements and training concepts This was also illustrated by the demonstration by Hessian HRD dogs directly adjacent to the conference venue – bloody knives old bones and items of clothing from cadavers were well hidden in the bushes waiting to be sniffed out by the canine detectives from Germany and Belgium head of the dog training unit in Mühlheim am Main stressed how important it is to train the dogs using real human cadavers – which of course cannot be done just anywhere but requires a dedicated location – like a body farm Shari Forbes and her European colleagues described the immediate practical relevance and also the great variety of research fields in the work on human cadavers the human microbiome can act as a marker indicating the time of a person’s death while the natural traces found on corpses are nowhere near being fully cataloged and understood and the complex chemistry of the “smell of death” can be a fascinating forensic tool for determining the post-mortem interval and the circumstances of a murder Another conference session focused on a species of insect that appears unremarkable at first glance: the blue blowfly It is the “gold standard” among the European necrophagous insects because it is one of the fly species most frequently found on corpses and is also well suited to the low temperatures that still often occur in Central Europe Insects on cadavers help in estimating the time of death which is very important in cases of homicide if more than one or two days have passed post mortem the classical forensic methods like body temperature rigor mortis and livor mortis no longer provide useful information it is possible to determine a post-mortem interval of up to several weeks based on the age of the insects present on the cadaver – and Calliphora vicina is very important here owing to its frequent occurrence the Czech Republic and Frankfurt provided examples that revealed how complicated it can be to determine insects’ age in actual case work and how important it is to learn more about the factors that influence these cold-blooded creatures such as fluctuating diurnal temperature profiles Necrophagous insects are at the end of the food chain – and when they feed on a corpse they also consume those substances that the deceased consumed more or less regularly during their lifetime a large number of contributions examined the extent to which substances such as various benzodiazepines can be detected in the insects if human tissue samples no longer exist or can no longer be analyzed and whether consumption of these substances can alter the insects’ ageing process That would have an impact on the estimated time of death The data presented from Munich and elsewhere allayed the fears of the audience as this kind of influence was thought to be extremely unlikely The conference presentations in the “free topics” section demonstrated the enormous range of activities in forensic entomology: analyses of the genetic diversity of carrion insects ecological investigations of the insect succession on dead flesh new types of indicators like the invasive blowfly Chrysomya albiceps and techniques adapted from other disciplines for creating a timeline for the weathering of insect remains at the site of a cadaver A veritable cornucopia of methods was presented which was matched by the comprehensive range of specialists attending the conference: from forensic pathologists to curators of natural history museums all the way to employees at the most varied (inter)national criminal investigation departments The large number of contributions from early career scientists was also welcome – a total of 14 lectures and posters were “assessed” by the conference’s participants The final panel discussion addressed a major problem in forensic entomology Whereas “genetic fingerprints” and the “virtual 3-D crime scene” are firmly established methods for investigators all too often insects still lead something of a Cinderella existence at the European level The forensic project “MaDE in Deutschland” (“Maggot in Germany”) in Frankfurt is intended to remedy this situation with funding from the EU serving as a best practice for other European professional development and information projects the attendees enjoyed the wine tasting that concluded the event all the more – Ingelheim showed its best side here It will be interesting to see whether next year’s conference venue can keep up the standard In culinary terms this should not be a problem Jens Amendt is responsible for the entomological assessment of homicides and unclear circumstances of death and teaches and researches the subject of forensic entomology at Goethe University Frankfurt He is also a founding member and the current president of the European Association for Forensic Entomology and is a board member of the German Society of Medical Entomology and Acarology (DGMEA) Im Sprach-Welt-Café treffen Studierende auf ganz unterschiedliche Sprachen Studentische Literaturzeitschrift schaut hoffnungsvoll in die Zukunft nämlich 2014: Die Goethe-Universität blickte auf 100 Jahre Studierende erhielten Einblicke in das praktische Versuchswesen und in Studienangebote anderer Hochschulen Auf Initiative des Schwerpunktes Ökotoxikologie im Masterstudiengang Umweltwissenschaften Studentische Initiativen und Fachschaften der Goethe-Uni stellen ihr Engagement vor Ende Mai fand im Casino am Campus Westend der „Tag Wie begeistern Biologielehrer*innen Schüler*innen für ihr Fach Im ersten „Workshop on Biological Sciences“ trafen acht Studierende des Kibbutzim College of Frankfurter Wissenschaftler vertritt deutsche Forschungslandschaft bei UN-Umweltkonferenzen bei denen der Fokus auf internationalem Abfallhandel und Chemikaliensicherheit liegt Die Goethe-Universität Frankfurt zuletzt als Joint Researcher am C3S und am Potsdam-Institut für Klimafolgenforschung Frankfurter Städel Museum und Arbeitsbereich Altersmedizin der Goethe-Universität entwickeln App für Menschen mit Demenz Demenz ist bislang nicht heilbar Wie die klassische Methode der Hirnstrommessung bei der Schlaganfalltherapie eine Renaissance erlebt Die klinische Neurophysiologie befindet sich in einer spannenden Wie MRT-Bilder bei Diagnose und Therapie von Hirntumoren helfen können Hirntumoren – Gliome – sind schwer zu behandeln und deshalb © 2024 Goethe-Universität Frankfurt am Main | Imprint | Datenschutzerklärung | Cookies verwalten Connecting decision makers to a dynamic network of information Bloomberg quickly and accurately delivers business and financial information and Boehringer Ingelheim International GmbH settled Cipla’s preemptive lawsuit over its proposed generic version of the rare-lung-disease treatment Ofev agreeing that the copy doesn’t infringe two patents and clearing Cipla’s path to launch six months earlier than a regulatory provision otherwise would’ve allowed According to a proposed consent decree and final judgment filed Thursday in the US District Court for the District of Delaware “Cipla may rely on this final judgment of non-infringement” of the patents as to its application for the US Food and Drug Administration’s approval of its proposed Ofev copy “to the extent permitted by .. workflow tools and premium legal & business news Log in to keep reading or access research tools Not all German tuning firms are obsessed with insane power numbers and questionable cosmetic makeovers, as Senner Tuning’s new package for the Mercedes-Benz SLS AMG Gullwing sports car shows The Ingelheim am Rhein-based tuner starts with the SLS AMG’s 6.2-liter V8 engine, which normally produces an output of 571-horsepower and a peak torque of 650Nm (479 lb-ft). A revised ECU along with a stainless steel sports exhaust system and a high-performance air filter boots these numbers 606HP and 690Nm (509 lb-ft). Senner Tuning also upgrades the suspension and adds a new set of 20-inch Corniche Vegas alloy wheels shod in tires size 255/30R20 at the front and 285/30R20 at the rear The carbon fiber mirror caps round off the package which carries a sticker price of €19,500 including VAT (about US$25,490) in Germany The IBB Hotel Ingelheim is the winner of the Best of Wine Tourism Award The coveted prize was awarded by international network Great Wine Capitals IBB Hotel Ingelheim forms part of the IBB Hotel Collection The IBB Hotel Collection currently operates 13 hotels in Germany This special honour for the Mainz and Rheinhessen regions in the ‘Accommodations’ category was awarded to the IBB Hotel Ingelheim following its opening for business in the Rheinhessen wine metropolis in 2017 The prize is awarded annually to companies that are particularly outstanding in their respective region for wine tourism A nine-member jury chose winners in seven categories – from fine food and wines to sustainability The interior design of the 109-room hotel reflects the Rheinhessen wine region: natural materials are mingled with images and stylistic elements from the world of wine Offerings such as wine events with partner wineries in their in-house restaurant and excursions to the vineyards by vintage bus also include a top selection of regional wines “It is a great honour that our IBB Hotel Ingelheim has been awarded this prestigious international prize successful wine tourism activities of our team led by general manager Michael Werner,” says IBB Hotel Collection managing director Vladimir Saal.  The modern hotel in the centre of the historic city of Ingelheim am Rhein is one of the individual city hotels in the fast-growing IBB Hotel Collection Strategically located just outside the Mainz/ Wiesbaden/Frankfurt and Rhine-Main metropolitan regions Its guests include business travellers and private visitors from Germany and abroad Through its immediate proximity to the kING Culture and Congress Hall and the Ingelheim iCC Conference Centre the hotel has established itself as an important hub for events in the region after just one year please register for free or log in to your account.